What is it about?
There is 13.3 % Xalatan non-responder dogs in primary glaucoma.
Featured Image
Why is it important?
With long-term use of 0.005% latanoprost (over 4 months), the IOP tended to remain suppressed to a low level. Topical application of 0.005% latanoprost controlled IOP long-term in 43.8% of dogs with primary glaucoma. The remaining dogs had either no response to this treatment, or showed a temporary decrease in IOP.
Read the Original
This page is a summary of: Primary Glaucoma and Long- Term Topical Application of 0.005% Latanoprost Effects on Intraocular Pressure in Uncontrollable used Multidrug Medications or Single used in Dogs, Journal of Veterinary Science & Medical Diagnosis, January 2015, OMICS Publishing Group,
DOI: 10.4172/2325-9590.1000171.
You can read the full text:
Contributors
The following have contributed to this page
